{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:12:24Z","timestamp":1792156344719,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ygyno.2021.12.017","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T20:31:18Z","timestamp":1640205078000},"page":"421-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Patient reported outcomes after risk-reducing surgery in patients at increased risk of ovarian cancer"],"prefix":"10.1016","volume":"164","author":[{"given":"L.","family":"Philp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Alimena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Bregar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"del Carmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.L.","family":"Eisenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.B.","family":"Growdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Dorney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Mazina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C.","family":"Sisodia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"41","key":"10.1016\/j.ygyno.2021.12.017_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","article-title":"Epidemiology of epithelial ovarian cancer","volume":"2017","author":"Webb","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"10.1016\/j.ygyno.2021.12.017_bb0010","first-page":"2015","article-title":"Hereditary ovarian cancer: Not only BRCA 1 and 2 Genes","author":"Toss","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ygyno.2021.12.017_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bpobgyn.2016.10.017","article-title":"Hereditary ovarian Cancer and risk reduction","volume":"41","author":"Andrews","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"issue":"9","key":"10.1016\/j.ygyno.2021.12.017_bb0020","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA - J. Am. Med. Assoc."},{"issue":"9","key":"10.1016\/j.ygyno.2021.12.017_bb0025","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrclinonc.2016.90","article-title":"Counselling framework for moderate-penetrance cancer susceptibility mutations","volume":"13","author":"Tung","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.017_bb0030","series-title":"Genetic \/ Familial High-Risk Assessment\u202f: Breast, Ovarian, and Pancreatic","author":"Clinical","year":"2022"},{"issue":"2","key":"10.1016\/j.ygyno.2021.12.017_bb0035","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1245\/s10434-016-5688-z","article-title":"Society of Surgical Oncology breast disease working group statement on prophylactic (risk-reducing) mastectomy","volume":"24","author":"Hunt","year":"2017","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.12.017_bb0040","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s10897-016-9949-6","article-title":"Psychological distress, anxiety, and depression of Cancer-affected BRCA1\/2 mutation carriers: a systematic review","volume":"25","author":"Ringwald","year":"2016","journal-title":"J. Genet. Couns."},{"issue":"3","key":"10.1016\/j.ygyno.2021.12.017_bb0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1158\/1055-9965.EPI-11-0991","article-title":"Long-term psychosocial outcomes of BRCA1\/BRCA2 testing: differences across affected status and risk-reducing surgery choice","volume":"21","author":"Graves","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"10.1016\/j.ygyno.2021.12.017_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/cge.12298","article-title":"The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers","volume":"85","author":"Borreani","year":"2014","journal-title":"Clin. Genet."},{"issue":"9","key":"10.1016\/j.ygyno.2021.12.017_bb0055","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1245\/s10434-017-5915-2","article-title":"Impact of bilateral prophylactic mastectomy and immediate reconstruction on health-related quality of life in women at high risk for breast carcinoma: results of the mastectomy reconstruction outcomes consortium study","volume":"24","author":"McCarthy","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.017_bb0060","first-page":"1","article-title":"Sexual function, menopausal symptoms, depression and cancer worry in women with BRCA mutations","author":"Powell","year":"2019","journal-title":"Psychooncology."},{"issue":"10","key":"10.1016\/j.ygyno.2021.12.017_bb0065","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.bjps.2007.08.006","article-title":"Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction","volume":"61","author":"Isern","year":"2008","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"issue":"6","key":"10.1016\/j.ygyno.2021.12.017_bb0070","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s11136-015-1181-6","article-title":"Quality of life among patients after bilateral prophylactic mastectomy: a systematic review of patient-reported outcomes","volume":"25","author":"Razdan","year":"2016","journal-title":"Qual. Life Res."},{"issue":"1","key":"10.1016\/j.ygyno.2021.12.017_bb0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ygyno.2008.12.024","article-title":"A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer","volume":"113","author":"Michelsen","year":"2009","journal-title":"Gynecol Oncol [Internet]."},{"issue":"28","key":"10.1016\/j.ygyno.2021.12.017_bb0080","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","article-title":"Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer","volume":"23","author":"Madalinska","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"20","key":"10.1016\/j.ygyno.2021.12.017_bb0085","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.2003.10.100","article-title":"Long-term psychological impact of carrying a BRCA1\/2 mutation and prophylactic surgery: a 5-year follow-up study","volume":"21","author":"van Oostrom","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.12.017_bb0090","first-page":"1","article-title":"Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers?","volume":"27","author":"Kotsopoulos","year":"2019","journal-title":"Menopause."},{"issue":"5","key":"10.1016\/j.ygyno.2021.12.017_bb0095","first-page":"278","article-title":"Patient-reported outcomes in Cancer: a review of recent research and policy initiatives","volume":"57","author":"Lipscomb","year":"2007","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.ygyno.2021.12.017_bb0100","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1200\/JCO.2007.13.3439","article-title":"The prognostic significance of patient-reported outcomes in cancer clinical trials","volume":"26","author":"Gotay","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.12.017_bb0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2017.11.011","article-title":"The use of patient-reported outcome tools in gynecologic oncology research, clinical practice, and value-based care","volume":"148","author":"Moss","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"34","key":"10.1016\/j.ygyno.2021.12.017_bb0110","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1200\/JCO.2012.42.5967","article-title":"Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology","volume":"30","author":"Basch","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.12.017_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1099-1611(199805\/06)7:3<263::AID-PON307>3.0.CO;2-Q","article-title":"\u201cYou don\u2019t want to lose your ovaries because you think \u2018I might become a man\u2019\u201d. Women\u2019s perceptions of prophylactic surgery as a cancer risk management strategy","volume":"7","author":"Hallowell","year":"1998","journal-title":"Psychooncology."},{"issue":"1","key":"10.1016\/j.ygyno.2021.12.017_bb0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejca.2006.09.009","article-title":"The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and\/or salpingo-oophorectomy","volume":"43","author":"Bresser","year":"2007","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2021.12.017_bb0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0090-8258(03)00072-6","article-title":"Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy","volume":"89","author":"Robson","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.12.017_bb0130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/gyno.2002.6737","article-title":"Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study","volume":"86","author":"Tiller","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.12.017_bb0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10689-014-9761-0","article-title":"The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome","volume":"14","author":"Moldovan","year":"2015","journal-title":"Familial Cancer"},{"issue":"3\u20134","key":"10.1016\/j.ygyno.2021.12.017_bb0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1021119405814","article-title":"Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer","volume":"1","author":"Elit","year":"2001","journal-title":"Familial Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.12.017_bb0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10689-010-9384-z","article-title":"What i wish I\u2019d known before surgery: BRCA carriers\u2019 perspectives after bilateral salipingo-oophorectomy","volume":"10","author":"Campfield Bonadies","year":"2011","journal-title":"Familial Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.12.017_bb0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ygyno.2015.11.002","article-title":"Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy","volume":"140","author":"Tucker","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.12.017_bb0155","first-page":"87","article-title":"Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction","volume":"46","author":"Swisher","year":"2001","journal-title":"J Reprod Med."},{"issue":"2","key":"10.1016\/j.ygyno.2021.12.017_bb0160","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2016.03.003","article-title":"The health-related quality of life journey of gynecologic oncology surgical patients: implications for the incorporation of patient-reported outcomes into surgical quality metrics","volume":"141","author":"Doll","year":"2016","journal-title":"Gynecol Oncol [Internet]."},{"issue":"2017","key":"10.1016\/j.ygyno.2021.12.017_bb0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejca.2017.07.018","article-title":"Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: a prospective study","volume":"84","author":"Vermeulen","year":"2017","journal-title":"Eur J Cancer [Internet]."},{"issue":"2","key":"10.1016\/j.ygyno.2021.12.017_bb0170","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygyno.2010.07.009","article-title":"Symptom research in gynecologic oncology: a review of available measurement tools","volume":"119","author":"Agarwal","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.017_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-9-86","article-title":"Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science","volume":"9","author":"McKenna","year":"2011","journal-title":"BMC Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821016747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821016747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:59:10Z","timestamp":1758772750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821016747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0090825821016747"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.12.017","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient reported outcomes after risk-reducing surgery in patients at increased risk of ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}